lenti-SpCas9 blast Citations (6)
Originally described in: A reference collection of patient-derived cell line and xenograft models of proneural, classical and mesenchymal glioblastoma.Stringer BW, Day BW, D'Souza RCJ, Jamieson PR, Ensbey KS, Bruce ZC, Lim YC, Goasdoue K, Offenhauser C, Akgul S, Allan S, Robertson T, Lucas P, Tollesson G, Campbell S, Winter C, Do H, Dobrovic A, Inglis PL, Jeffree RL, Johns TG, Boyd AW Sci Rep. 2019 Mar 20;9(1):4902. doi: 10.1038/s41598-019-41277-z. PubMed Journal
Articles Citing lenti-SpCas9 blast
| Articles |
|---|
Stimulation of CRISPR-mediated homology-directed repair by an engineered RAD18 variant.
Nambiar TS, Billon P, Diedenhofen G, Hayward SB, Taglialatela A, Cai K, Huang JW, Leuzzi G, Cuella-Martin R, Palacios A, Gupta A, Egli D, Ciccia A.
Nat Commun. 2019 Jul 30;10(1):3395. doi: 10.1038/s41467-019-11105-z.
PubMed
Associated Plasmids |
| Proteomic Analysis Identifies Membrane Proteins Dependent on the ER Membrane Protein Complex. Tian S, Wu Q, Zhou B, Choi MY, Ding B, Yang W, Dong M. Cell Rep. 2019 Sep 3;28(10):2517-2526.e5. doi: 10.1016/j.celrep.2019.08.006. PubMed |
| Inhibition of mitochondrial translation suppresses glioblastoma stem cell growth. Sighel D, Notarangelo M, Aibara S, Re A, Ricci G, Guida M, Soldano A, Adami V, Ambrosini C, Broso F, Rosatti EF, Longhi S, Buccarelli M, D'Alessandris QG, Giannetti S, Pacioni S, Ricci-Vitiani L, Rorbach J, Pallini R, Roulland S, Amunts A, Mancini I, Modelska A, Quattrone A. Cell Rep. 2021 Apr 27;35(4):109024. doi: 10.1016/j.celrep.2021.109024. PubMed |
| Emerging enterococcus pore-forming toxins with MHC/HLA-I as receptors. Xiong X, Tian S, Yang P, Lebreton F, Bao H, Sheng K, Yin L, Chen P, Zhang J, Qi W, Ruan J, Wu H, Chen H, Breault DT, Wu H, Earl AM, Gilmore MS, Abraham J, Dong M. Cell. 2022 Mar 31;185(7):1157-1171.e22. doi: 10.1016/j.cell.2022.02.002. Epub 2022 Mar 7. PubMed |
| Targeted intracellular delivery of Cas13 and Cas9 nucleases using bacterial toxin-based platforms. Tian S, Liu Y, Appleton E, Wang H, Church GM, Dong M. Cell Rep. 2022 Mar 8;38(10):110476. doi: 10.1016/j.celrep.2022.110476. PubMed |
| Combining Multiplexed CRISPR/Cas9-Nickase and PARP Inhibitors Efficiently and Precisely Targets Cancer Cells. Lee S, Kim K, Jeong HJ, Choi S, Cheng H, Kim D, Heo S, Mun J, Kim M, Lee E, Choi YJ, Lee SG, Lee EA, Jang Y, Lim K, Kim HS, Jeong E, Myung SJ, Jung DB, Yu CS, Song IH, Corces MR, Kang JH, Myung K, Kwon T, Park TE, Joo J, Cho SW. Cancer Res. 2025 Aug 1;85(15):2890-2904. doi: 10.1158/0008-5472.CAN-24-2938. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.